Inetetamab

Product Description: Inetetamab is a monoclonal antibody binding to domain IV of HER2 receptor. Inetetamab alone or together with tyrosine kinase inhibitors has antitumor activities[1][2].

Applications: Cancer-Kinase/protease

Formula: N/A

References: [1]Min Yan, et al. Anti-HER2 antibody inetetamab plus camrelizumab and utidelone for pretreated HER2-positive advanced breast cancer: A single-arm, multicenter, phase 2 study. Journal of Clinical Oncology. 2022. 40 (16), e13030-e13030. /[2]Deng L,et al. Systemic investigation of inetetamab in combination with small molecules to treat HER2-overexpressing breast and gastric cancers. Open Life Sci. 2023 Jan 10;18(1):20220535.

Molecular Weight: N/A

Compound Purity: 96.54

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: EGFR

• Artikelnummer: MEXHY-P99969-1
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99969-1
• Verpackungseinheit: 1 mg
• Mengeneinheit: STK
• Konjugat: Unconjugated